Reference
Santarsieri A, et al. Modification of escalated beacopp with dacarbazine substitution reduces toxicity while maintaining efficacy for the treatment of advancedstage hodgkin lymphoma. HemaSphere 5 (Suppl.): 349-350, Jun 2021. Available from: URL: http://doi.org/10.1097/HS9.0000000000000566 [abstract]
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1873, 32 (2021). https://doi.org/10.1007/s40278-021-02455-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-02455-3